aTyr Pharma | LIFE - Assets

Stock Price
0.81
Daily Change
-0.07 -7.95%
Monthly
11.97%
Yearly
-79.04%
Q1 Forecast
0.86

aTyr Pharma reported $106.65M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Ardelyx USD 486.17M 19.4M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 39.4B 957M Jun/2025
Galapagos EUR 3.51B 306.31M Sep/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
United Therapeutics USD 7.35B 556.9M Sep/2025